Worldwide Offers Accessibility and Therapeutic Focus for Your Meningitis Study

Meningitis, or meningococcal disease, is an inflammation of the membranes protecting the brain and spinal cord. The disease has a high mortality rate, and its effects can persist in individuals who survive the disease. Current research seeks to uncover causes of the condition, the safety and tolerability of vaccines, and the effectiveness of new treatment therapies.

Worldwide Clinical Trials has been exploring challenging central nervous system conditions since the 1970s, and its medical, science, and research professionals have been at the forefront of the development of pharmacological therapies for CNS-related illnesses for much of that time. Recognizing that participation in a meningitis study involves a heavy patient burden, we are able to balance the needs of the patient with the operational requirements of our investigator site staff. We assign a specialist team to your project as part of our study design and execution strategy. This way, you can be assured of our focused expertise and accessibility during your meningitis clinical trial.